Joshua Salomon Stanford Health Policy

Joshua Salomon, PhD

  • Professor, Health Policy
  • Senior Fellow, Freeman Spogli Institute for International Studies
Encina Commons Room 114, 615 Crothers Way, Stanford, CA 94305-6006
(650) 736-9477 (voice)

Biography

Joshua Salomon is a Professor of Health Policy in the Department of Health Policy at Stanford School of Medicine, Senior Fellow in the Freeman Spogli Institute for International Studies, and founding Director of the Prevention Policy Modeling Lab. Trained in health policy and decision science, Dr. Salomon leads multidisciplinary research teams dedicated to producing rigorous, actionable evidence to improve the public’s health and reduce health disparities. His work — supported by the National Institutes of Health, Centers for Disease Control and Prevention, and the Bill & Melinda Gates Foundation — combines data synthesis and mathematical modeling to measure and forecast health outcomes and evaluate public health programs and strategies, with particular emphasis on infectious diseases. He has spearheaded methodological innovation in measurement and valuation of health, infectious disease modeling and forecasting, and cost-effectiveness analysis. His applied modeling work on HIV/AIDS, tuberculosis, viral hepatitis, COVID-19 and other major health challenges informs local, state, national and international policies to improve health and wellbeing, particularly among under-served populations in the United States and around the world.  

Dr. Salomon established the multi-institution Prevention Policy Modeling Lab in 2014 to conduct health and economic modeling that guides reasoned public health decision-making relating to infectious disease. He has co-authored more than three hundred original peer-reviewed research articles and mentored dozens of graduate and post-graduate trainees in health policy, medicine and public health. Prior to joining the Stanford Faculty, Dr. Salomon served as a policy analyst in the Department of Evidence and Information for Policy at the World Health Organization in Geneva, and as Professor of Global Health at Harvard T.H. Chan School of Public Health. As Associate Chair for Academic Affairs and Strategy in the Department of Health Policy at Stanford, he works on faculty recruitment and development, and leads strategic initiatives to promote interdisciplinary collaborative research, practice partnerships and policy translation.

In The News

Photo of Hepatitis B Test
Q&As

Researchers Team Up with CDC to Expand Hepatitis B Screening

Most Americans don’t know they may be infected with the hepatitis B virus, the leading cause of liver cancer around the world. Stanford researchers have been working with the CDC to provide evidence that screening every adult for the virus would not only be cost-effective, but could save many lives.
cover link Researchers Team Up with CDC to Expand Hepatitis B Screening
Getty Images illustration of COVID-19 vaccine vials
News

Protection Against Omicron from Vaccination and Previous Infection

Research using data from residents and staff in the California prison systems show that vaccinations offer good protection against infection with Omicron, even among patients who had previous infections.
cover link Protection Against Omicron from Vaccination and Previous Infection
COVID-19 mask graffiti
News

Effectiveness of the COVID-19 Vaccine in One California Prison

The latest study by the Stanford Health Policy COVID-19 modeling team shows that vaccination continues to provide powerful protection from the delta variant, even among people who have been infected before.
cover link Effectiveness of the COVID-19 Vaccine in One California Prison